IN VITRO DIAGNOSTICS Mergers & Acquisitions Signal Genetics LLC ChipDx LLC Predictive testing company Signal Genetics Inc. has acquired privately held ChipDX LLC (molecular diagnostics for can
Navidea Biopharmaceuticals , headquartered in Dublin, Ohio specializes in the development and commercialization of radiopharmaceutical products that assist in the diagnosis of cancers and neurodegener
Belgian biotech company Amakem has begun a proof-of-concept study with its lead product, the rho kinase (ROCK) inhibitor AMA0076, in glaucoma and ocular hypertension, after raising €18 million last ye
Harry Tracy, a publisher and consultant who tracks the neurotherapeutics space, calls the partnering environment for central nervous system drugs “dismal” and “ugly.” He’s not far off the mark. While